Literature DB >> 11894730

Inflammatory mediators in cystic fibrosis lung disease.

Melvin Berger1.   

Abstract

Cystic fibrosis (CF) is a complex multisystem disorder caused by mutations in a membrane glycoprotein called the CF transmembrane regulator (CFTR), which has as its major function serving as a Cl- channel. The relationship between defects in CFTR and development of lung disease remains incompletely understood. Chronic lung disease, characterized by persistent infection with a peculiar type of Pseudomonas aeruginosa, bronchiectasis, and airway obstruction is the major cause of morbidity and mortality in CF patients. The inflammatory response to the chronic infection resembles that induced by lipopolysaccharide (LPS) and is mediated primarily by cytokines such as tumor necrosis factor (TNF), interleukin-1 (IL-1), IL-6, and IL-8, whose synthesis is activated by the transcription factor nuclear factor kappa B (NF-kappa B). Large numbers of neutrophils dominate the inflammatory response and excessive concentrations of their products create a vicious cycle that becomes injurious rather than protective and eventually claims the life of the patient.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11894730

Source DB:  PubMed          Journal:  Allergy Asthma Proc        ISSN: 1088-5412            Impact factor:   2.587


  22 in total

Review 1.  Role of endoplasmic reticulum stress in cystic fibrosis-related airway inflammatory responses.

Authors:  Carla M P Ribeiro; Richard C Boucher
Journal:  Proc Am Thorac Soc       Date:  2010-11

2.  Anti-inflammatory Effects of Ganoderma lucidum Triterpenoid in Human Crohn's Disease Associated with Downregulation of NF-κB Signaling.

Authors:  Changda Liu; David Dunkin; Joanne Lai; Ying Song; Clare Ceballos; Keith Benkov; Xiu-Min Li
Journal:  Inflamm Bowel Dis       Date:  2015-08       Impact factor: 5.325

3.  Activation of the pyrin inflammasome by intracellular Burkholderia cenocepacia.

Authors:  Mikhail A Gavrilin; Dalia H A Abdelaziz; Mahmoud Mostafa; Basant A Abdulrahman; Jaykumar Grandhi; Anwari Akhter; Arwa Abu Khweek; Daniel F Aubert; Miguel A Valvano; Mark D Wewers; Amal O Amer
Journal:  J Immunol       Date:  2012-02-24       Impact factor: 5.422

4.  Similarity of gene expression patterns in human alveolar macrophages in response to Pseudomonas aeruginosa and Burkholderia cepacia.

Authors:  Stefan Worgall; Adriana Heguy; Karsta Luettich; Timothy P O'Connor; Ben-Gary Harvey; Luis E N Quadri; Ronald G Crystal
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

5.  A549 lung epithelial cells grown as three-dimensional aggregates: alternative tissue culture model for Pseudomonas aeruginosa pathogenesis.

Authors:  A J Carterson; K Höner zu Bentrup; C M Ott; M S Clarke; D L Pierson; C R Vanderburg; K L Buchanan; C A Nickerson; M J Schurr
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

Review 6.  Micro-RNAs in inflammatory diseases and as a link between inflammation and cancer.

Authors:  R Ranjha; J Paul
Journal:  Inflamm Res       Date:  2013-02-17       Impact factor: 4.575

7.  Endoplasmic reticulum stress induced by surfactant protein C BRICHOS mutants promotes proinflammatory signaling by epithelial cells.

Authors:  Jean Ann Maguire; Surafel Mulugeta; Michael F Beers
Journal:  Am J Respir Cell Mol Biol       Date:  2010-05-12       Impact factor: 6.914

8.  Attenuation of host defense function of lung phagocytes in young cystic fibrosis patients.

Authors:  Neil E Alexis; Marianne S Muhlebach; David B Peden; Terry L Noah
Journal:  J Cyst Fibros       Date:  2005-12-13       Impact factor: 5.482

9.  The Pseudomonas aeruginosa lipid A deacylase: selection for expression and loss within the cystic fibrosis airway.

Authors:  Robert K Ernst; Kristin N Adams; Samuel M Moskowitz; Gretchen M Kraig; Kiyoshi Kawasaki; Christopher M Stead; M Stephen Trent; Samuel I Miller
Journal:  J Bacteriol       Date:  2006-01       Impact factor: 3.490

10.  Th2 allergic immune response to inhaled fungal antigens is modulated by TLR-4-independent bacterial products.

Authors:  Jenna B Allard; Lisa Rinaldi; Matthew J Wargo; Gilman Allen; Shizuo Akira; Satoshi Uematsu; Matthew E Poynter; Deborah A Hogan; Mercedes Rincon; Laurie A Whittaker
Journal:  Eur J Immunol       Date:  2009-03       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.